Skip to search formSkip to main contentSkip to account menu

furoxan

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

1,2,5-oxadiazole 2-oxidefuroxans

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Synthesis and antitumor evaluation of novel hybrids of phenylsulfonylfuroxan and epiandrosterone/dehydroepiandrosterone derivatives
2015
2015
New thermally stable energetic materials: synthesis and characterization of guanylhydrazone substituted furoxan energetic derivatives
New guanylhydrazone substituted furoxan energetic derivatives were synthesized via the condensation reactions of 3-methyl-4… 
Highly Cited
2012
Highly Cited
2012
Antitumor platinum(II) complexes containing platinum-based moieties of present platinum drugs and furoxan groups as nitric oxide donors: synthesis, DNA interaction, and cytotoxicity.
Six novel platinum(II) complexes 1-6 bearing different furoxan moieties as nitric oxide (NO) donors have been designed… 
2012
2012
Synthesis and evaluation of nitric oxide-releasing DDB derivatives as potential Pgp-mediated MDR reversal agents in MCF-7/Adr cells.
2007
2007
Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
The structure of fenoterol, a beta2-adrenoceptor agonist used in therapy, has been joined with furoxan NO-donor moieties to give… 
2005
2005
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX‐2 Endowed with Anti‐Aggregatory and Vasodilating Activities
Several NO donor 3,4‐diphenylfuroxan (=3,4‐diphenyl‐1,2,5‐oxadiazole 2‐oxide) derivatives were synthesized and tested for their… 
2005
2005
Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogs.
2004
2004
Monocyclic and cascade rearrangements of furoxans
Monocyclic rearrangements of azoles are extensively studied as alternative methods for the preparation of new heterocyclic… 
1996
1996
The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363
1 The mechanism of action and the pharmacological effects of the new furoxan derivative, CHF 2363 (4‐ethoxy‐3… 
1994
1994
CHF 2206, a new potent vasodilating and antiaggregating drug as potential nitric oxide donor.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)